Tower Research Capital LLC (Trc) Kiniksa Pharmaceuticals, Ltd. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$17.63 - $21.74 $168,084 - $207,269	-9,534 Reduced 92.64%	758 $14,000
Q4 2023 Feb 13, 2024	BUY	$14.37 - $19.07 $129,444 - $171,782	9,008 Added 701.56%	10,292 $180,000
Q3 2023 Nov 14, 2023	SELL	$13.62 - $20.2 $12,503 - $18,543	-918 Reduced 41.69%	1,284 $22,000
Q2 2023 Aug 14, 2023	SELL	$10.44 - $16.48 $28,323 - $44,710	-2,713 Reduced 55.2%	2,202 $31,000
Q1 2023 May 09, 2023	BUY	$10.7 - $15.79 $42,810 - $63,175	4,001 Added 437.75%	4,915 $53,000
Q4 2022 Feb 10, 2023	SELL	$11.42 - $17.05 $24,701 - $36,879	-2,163 Reduced 70.3%	914 $13,000
Q3 2022 Nov 10, 2022	SELL	$9.76 - $13.41 $11,741 - $16,132	-1,203 Reduced 28.11%	3,077 $39,000
Q2 2022 Aug 15, 2022	BUY	$7.6 - $11.41 $13,338 - $20,024	1,755 Added 69.5%	4,280 $42,000
Q1 2022 May 12, 2022	SELL	$9.3 - $12.37 $50,768 - $67,527	-5,459 Reduced 68.37%	2,525 $25,000
Q4 2021 Feb 14, 2022	BUY	$10.39 - $15.15 $36,468 - $53,176	3,510 Added 78.45%	7,984 $94,000
Q3 2021 Nov 15, 2021	SELL	$11.39 - $16.23 $11,697 - $16,668	-1,027 Reduced 18.67%	4,474 $50,000
Q2 2021 Aug 16, 2021	BUY	$13.22 - $19.09 $55,087 - $79,548	4,167 Added 312.37%	5,501 $77,000
Q1 2021 May 17, 2021	SELL	$16.68 - $23.97 $23,618 - $33,941	-1,416 Reduced 51.49%	1,334 $25,000
Q4 2020 Feb 16, 2021	SELL	$14.8 - $21.15 $246,730 - $352,591	-16,671 Reduced 85.84%	2,750 $49,000
Q3 2020 Nov 16, 2020	BUY	$15.21 - $25.53 $254,508 - $427,193	16,733 Added 622.51%	19,421 $298,000
Q2 2020 Aug 13, 2020	BUY	$15.08 - $26.0 $18,910 - $32,604	1,254 Added 87.45%	2,688 $68,000
Q1 2020 May 15, 2020	SELL	$11.0 - $19.76 $59,180 - $106,308	-5,380 Reduced 78.96%	1,434 $22,000
Q4 2019 Feb 07, 2020	BUY	$5.24 - $12.96 $35,548 - $87,920	6,784 Added 22613.33%	6,814 $76,000
Q3 2019 Nov 05, 2019	BUY	$8.15 - $15.88 $244 - $476	30 New	30 $0
Q2 2019 Aug 13, 2019	SELL	$13.2 - $20.39 $6,573 - $10,154	-498 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$15.93 - $26.59 $7,933 - $13,241	498 New	498 $9,000
Q4 2018 Feb 14, 2019	SELL	$16.25 - $28.09 $19,483 - $33,679	-1,199 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$13.23 - $30.93 $12,819 - $29,971	969 Added 421.3%	1,199 $31,000
Q2 2018 Aug 15, 2018	BUY	$16.73 - $20.35 $3,847 - $4,680	230 New	230 $4,000

Others Institutions Holding KNSA

# of Institutions

Shares Held

1.95M

Call Options Held

Put Options Held

Pictet Asset Management Sa Geneva 73, V8

1.52M
Shares

$30.2 Million
0.03% of portfolio
Spearhead Capital Advisors, LLC Wellington, FL

203K
Shares

$4.04 Million
2.82% of portfolio
Harbor Capital Advisors, Inc.

98.1K
Shares

$1.95 Million
0.08% of portfolio
Putnam Investments LLC Boston, MA

39.5K
Shares

$786,955
0.0% of portfolio
Birchview Capital, LP Burlington, VT

30K
Shares

$597,900
0.69% of portfolio

View Full List

About Kiniksa Pharmaceuticals, Ltd.

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $687M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

More about KNSA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account